Acarix AB (OSTO:ACARIX) Total Equity: kr43.78 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:ACARIX Acarix AB OSTO:ACARIX
39 GF Score
Price kr0.23
GF Value kr0.28
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Acarix AB Total Equity?

Acarix AB OSTO:ACARIX -0.85% 39 Total Equity is kr43.78 Mil as of Jun. 2026. GuruFocus rates OSTO:ACARIX with a GF Score™ of 39/100 and a GF Value™ of kr0.28 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Acarix AB's total equity for the quarter that ended in Jun. 2026 was kr43.78 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Acarix AB Total Equity Historical Data

* Premium members only.

The historical data trend for Acarix AB's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acarix AB Total Equity Chart

Acarix AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 100.54 51.83 51.89 75.70 38.17

Acarix AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 47.73 38.48 38.17 36.96 43.78
OSTO:ACARIX
39GF Score
Acarix AB OSTO:ACARIX
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Acarix AB Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Acarix AB's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=48.33-10.159
=38.17

Acarix AB's Total Equity for the quarter that ended in Jun. 2026 is calculated as

Total Equity=Total Assets(Q: Jun. 2026 )-Total Liabilities(Q: Jun. 2026 )
=47.739-3.962
=43.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of kr43.78 Mil mean?
Acarix AB (OSTO:ACARIX) has a Total Equity of kr43.78 Mil as of Jun. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Acarix AB and its competitors.
Is Acarix AB's Total Equity too high?
Acarix AB's current Total Equity is kr43.78 Mil. Overall, Acarix AB has a GF Score™ of 39/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Acarix AB's Total Equity compare to ABT and SYK?
Acarix AB's Total Equity of kr43.78 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Acarix AB and its competitors. Acarix AB's current Total Equity is kr43.78 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acarix AB stock overvalued right now?
Based on GuruFocus' analysis, Acarix AB (OSTO:ACARIX) is currently considered Modestly Undervalued. The stock's GF Value™ is kr0.28, compared to a current price of kr0.23 — trading 16.4% below its estimated fair value. The current Total Equity is kr43.78 Mil. Acarix AB's overall GF Score™ is 39/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Acarix AB (OSTO:ACARIX), the current Total Equity is kr43.78 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Acarix AB (OSTO:ACARIX) Overvalued in 2026?

Based on GuruFocus' analysis, Acarix AB stock appears to be undervalued. The current stock price of kr0.23 is trading 16.4% below its estimated GF Value™ of kr0.28. GuruFocus considers Acarix AB to be Modestly Undervalued.

Key valuation signals for OSTO:ACARIX:

  • Total Equity: kr43.78 Mil
  • GF Value™: kr0.28 vs. price of kr0.23 (16.4% below fair value)
  • GF Score™: 39/100 with 1 warning sign

No single metric tells the full story. See the OSTO:ACARIX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Acarix AB Business Description

Other Exchanges ACIXF:USA
Address Hyllie Boulevard 34, Regus Malmo, Malmo, SWE, 215 32
Acarix AB is a Swedish medical technology company that develops solutions for rapid AI-based exclusion of coronary artery disease (CAD). Its CE-marked CADScor System, which has also received DeNovo approval from the FDA, is intended for patients experiencing chest pain with suspected coronary artery disease and is designed to help reduce millions of cases of unnecessary, invasive, and costly diagnostics. Acarix recommends the CADScor System as a first-line diagnostic tool that uses sensitive acoustics and computational processing to analyze coronary blood flow to rule out coronary artery disease (CAD), with a majority certainty at the point of care. Geographically, the company generates maximum revenue from the United States, and the rest from Germany, Sweden, Iraq, and other regions.
39GF Score

Get the complete analysis for OSTO:ACARIX

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.23
Price
kr0.28
GF Value